Group One Trading
SGMO

Group One Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Group One Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36K Sell
145,700
-72,400
-33% -$28.8K ﹤0.01% 5521
2025
Q4 		$91.6K Sell
218,100
-84,900
-28% -$45K ﹤0.01% 5071
2025
Q3 		$204K Buy
303,000
+24,000
+9% +$12.9K ﹤0.01% 4648
2025
Q2 		$151K Sell
279,000
-166,300
-37% -$98.7K ﹤0.01% 4609
2025
Q1 		$292K Sell
445,300
-338,700
-43% -$359K ﹤0.01% 3629
2024
Q4 		$800K Buy
784,000
+399,500
+104% +$730K ﹤0.01% 2768
2024
Q3 		$333K Buy
384,500
+373,300
+3,333% +$273K ﹤0.01% 3169
2024
Q2 		$4.01K Sell
11,200
-166,100
-94% -$89.7K ﹤0.01% 6036
2024
Q1 		$119K Buy
177,300
+102,400
+137% +$74.3K ﹤0.01% 4015
2023
Q4 		$40.7K Buy
74,900
+38,500
+106% +$17.7K ﹤0.01% 5226
2023
Q3 		$21.8K Buy
36,400
+100
+0.3% +$107 ﹤0.01% 5824
2023
Q2 		$47.2K Buy
+36,300
New +$49.6K ﹤0.01% 5328
2023
Q1 		– Sell
-38,100
Closed -$120K – 7883
2022
Q4 		$120K Sell
38,100
-18,000
-32% -$69.9K ﹤0.01% 4276
2022
Q3 		$275K Buy
56,100
+3,200
+6% +$16.4K ﹤0.01% 3835
2022
Q2 		$219K Buy
52,900
+48,300
+1,050% +$209K ﹤0.01% 4215
2022
Q1 		$27K Sell
4,600
-16,300
-78% -$96.9K ﹤0.01% 6558
2021
Q4 		$157K Sell
20,900
-86,600
-81% -$752K ﹤0.01% 5329
2021
Q3 		$969K Buy
107,500
+65,500
+156% +$647K ﹤0.01% 3448
2021
Q2 		$503K Sell
42,000
-23,400
-36% -$265K ﹤0.01% 4217
2021
Q1 		$819K Sell
65,400
-97,200
-60% -$1.31M ﹤0.01% 3472
2020
Q4 		$2.54M Buy
162,600
+59,800
+58% +$701K ﹤0.01% 1856
2020
Q3 		$971K Sell
102,800
-59,400
-37% -$642K ﹤0.01% 2221
2020
Q2 		$1.45M Sell
162,200
-6,700
-4% -$62.2K 0.01% 1703
2020
Q1 		$1.08M Buy
168,900
+18,100
+12% +$134K 0.01% 1471
2019
Q4 		$1.26M Buy
150,800
+34,400
+30% +$316K 0.01% 1689
2019
Q3 		$1.05M Sell
116,400
-4,000
-3% -$44.9K 0.01% 1702
2019
Q2 		$1.3M Buy
120,400
+54,000
+81% +$574K 0.01% 1414
2019
Q1 		$633K Sell
66,400
-45,700
-41% -$467K 0.01% 1765
2018
Q4 		$1.29M Sell
112,100
-14,000
-11% -$174K 0.01% 1325
2018
Q3 		$2.14M Buy
126,100
+51,100
+68% +$777K 0.02% 1114
2018
Q2 		$1.06M Sell
75,000
-17,400
-19% -$289K 0.01% 1667
2018
Q1 		$1.76M Sell
92,400
-148,100
-62% -$3.17M 0.02% 1103
2017
Q4 		$3.94M Sell
240,500
-67,500
-22% -$1M 0.03% 773
2017
Q3 		$4.62M Buy
308,000
+117,800
+62% +$1.3M 0.04% 549
2017
Q2 		$1.67M Buy
190,200
+95,800
+101% +$615K 0.02% 1065
2017
Q1 		$491K Buy
94,400
+800
+0.9% +$3.21K 0.01% 1859
2016
Q4 		$285K Sell
93,600
-36,900
-28% -$134K ﹤0.01% 2180
2016
Q3 		$604K Buy
130,500
+93,400
+252% +$475K 0.01% 1677
2016
Q2 		$215K Sell
37,100
-4,500
-11% -$28.7K ﹤0.01% 2351
2016
Q1 		$252K Sell
41,600
-41,300
-50% -$248K ﹤0.01% 2175
2015
Q4 		$757K Buy
82,900
+31,300
+61% +$241K 0.01% 1512
2015
Q3 		$291K Sell
51,600
-85,900
-62% -$708K ﹤0.01% 2221
2015
Q2 		$1.52M Buy
137,500
+63,600
+86% +$820K 0.02% 912
2015
Q1 		$1.16M Sell
73,900
-79,400
-52% -$1.23M 0.02% 955
2014
Q4 		$2.33M Buy
153,300
+59,900
+64% +$727K 0.04% 567
2014
Q3 		$1.01M Sell
93,400
-20,200
-18% -$264K 0.02% 1116
2014
Q2 		$1.74M Sell
113,600
-16,500
-13% -$237K 0.03% 790
2014
Q1 		$2.35M Buy
130,100
+79,500
+157% +$1.53M 0.04% 548
2013
Q4 		$703K Buy
50,600
+16,400
+48% +$189K 0.01% 1379
2013
Q3 		$358K Sell
34,200
-20,900
-38% -$208K 0.01% 1899
2013
Q2 		$430K Buy
+55,100
New +$481K 0.01% 1477

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Group One Trading's SGMO Position: Q1 2026 in Review

Group One Trading reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 32% in Q1 2026, selling an estimated $63.6K and leaving 340,305 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #4880.

Group One Trading first reported a position in SGMO in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.35M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Group One Trading held 340,305 shares of SANGAMO THERAPEUTICS INC worth $84K as of Q1 2026.
  • Group One Trading sold 159,874 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $63.6K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4880 holding.
  • Group One Trading first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 50 quarters since.
  • Group One Trading's SANGAMO THERAPEUTICS INC position peaked at $4.35M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.